IDIBELL on the media
Positive Psychotherapy in patients who have completed cancer treatment
The new therapy, designed by the team of psychooncologist Cristian Ochoa, reduces long-term emotional distress and stress symptoms.
Discovery of a new mechanism of homeostatic plasticity in autaptic neural connections
A group from IDIBELL and UB has demonstrated that neurons can detect a decrease in the autaptic synapse, those established with themselves, and recover the consequent fall of neurotransmission by forming and enhancing new connections.
Bellvitge led the first post-coronavirus clinical trial for the treatment of patients with lung sequelae
The Fibro-Covid clinical trial will evaluate the ability of pirfenidone to prevent the establishment of irreversible and progressive fibrotic lesions in the lungs after overcoming Covid-19 pneumonia.
A web app with IDIBELL participation allows following the global evolution of the Covid-19 pandemic
A team of researchers developed a tool that integrates all epidemiological indicators and compares the evolution between countries.
The HUB-ICO-IDIBELL Biobank responds to the pandemic and creates a collection of COVID-19 samples for research
THE ICO-HUB-IDIBELL Biobank has created a collection of sera, plasma, DNA and RNA samples from patients confirmed by SARS-CoV-2 to make available to the scientific community
The fund against Covid-19 promoted by the ISCIII will finance three IDIBELL projects
The projects focus on the study of the virus biology, the immunity that generates and clinical manifestations of the disease.
Cells of the intestine nervous system and oligodendrocytes are affected in Parkinson’s disease
IDIBELL has participated in a study published in Nature Genetics that describes alterations in the neurons of the intestine and oligodendrocytes in Parkinson’s disease
Students from the “els Jesuïtes de Bellvitge” give their Vodafone Foundation award to IDIBELL
The sustainable development project ‘Junto@s por el clima’ (‘Together for the climate’) designed by the students has been awarded with 5,000 euros, that they have decided to give to IDIBELL.
